Overview

A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months

Status:
Completed
Trial end date:
2018-07-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to describe changes in the intensity of specific endometriosis symptoms from baseline pre-surgery to after surgery and subsequent continuous Diphereline (Triptorelin Acetate) treatment for up to 24 weeks.
Details
Lead Sponsor:
Ipsen
Treatments:
Triptorelin Pamoate